Pfizer (PFE)
$34.39
0.19 (0.56%)
PFE Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
201.17B
PE Ratio
9.55
EPS
3.6
Volume (Avg. Vol.)
30.59M
Day's Range
33.96 - 34.55
52-Week Range
27.88 - 43.08
Dividend & Yield
1.56 (4.54%)
PFE Stock Predictions, Articles, and Pfizer News
3 Reasons Pfizer Stock Will Have a Solid 2021
The vaccine will be a key. But there are other growth drivers for Pfizer stock.
Now More Than Ever Why Pfizer Stock Is a Buy
With 2020's proof in hand, it won't razzle dazzle Wall Street, but make no mistake, Pfizer stock can breathe life into investors portfolios
Hold Your Pfizer Shares Despite Hiccups in Vaccine Rollout
No need to let Covid-19 vaccine distribution issues deter you from owning Pfizer stock as the company still stands to earn massive revenues.
Pfizer Faces a New Perception Risk You Shouldn’t Ignore
Pfizer stock was earlier a key benefactor from the coronavirus vaccine race, but a new perceptional risk is weighing on shares.
When the Travel Sector Is Set to Take Off
The travel and hospitality industry is a sector that should thrive in 2021. In fact, travel is one of Eric Fry's four "Power Trends" in the new year.
3 Reasons To Invest in Pfizer Stock Despite Its Dismal Performance
Pfizer stock is down slightly so far this year despite an attractive valuation, high dividend yield and solid outlook. It's a value play.
For Pfizer, the Covid-19 Vaccine ‘Honeymoon’ Is Over
PFE stock never enjoyed the same run-up in the Covid-19 vaccine race as its competitors, even though it crossed the finish line first.
Ignore the Bears and Invest in Pfizer
Pfizer stock has been struggling mainly due to misapprehensions surrounding the company's Covid-19 vaccine and the depth of its portfolio.
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
